D. Pacheco

发表

Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors

I. Duarte, D. Pacheco, T. Romero, 2014, Brain Research.

Endogenous opioids regulate alveolar bone loss in a periodontal disease model.

T. Silva, C. Queiroz-Junior, D. Pacheco, 2013, Life sciences.

Crucial role of peripheral kappa-opioid receptors in a model of periodontal disease in rats.

C. Queiroz-Junior, M. Caliari, I. Duarte, 2008, Journal of periodontal research.

PnPP‐19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase

A. K. Carmona, M. E. Lima, I. Duarte, 2016, British journal of pharmacology.

Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors

I. Duarte, D. Pacheco, T. Romero, 2019, Neuroscience Letters.

Antinociceptive response in transgenic mice expressing rat tonin.

M. Bader, I. Duarte, D. Pacheco, 2013, European journal of pharmacology.

Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.

I. Duarte, D. Pacheco, T. Romero, 2013, Life sciences.

δ‐Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+‐activated Cl‐ channels

I. Duarte, D. Pacheco, C. F. Pacheco, 2012, The Journal of pharmacy and pharmacology.

Peripheral antinociception induced by δ-opioid receptors activation, but not μ- or κ-, is mediated by Ca²⁺-activated Cl⁻ channels.

I. Duarte, D. Pacheco, C. F. Pacheco, 2012, European journal of pharmacology.

Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.

A. Perez, I. Duarte, D. Pacheco, 2009, Life sciences.

δ-Opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels

I. Duarte, D. Pacheco, 2005 .

Inflammation Mobilizes Local Resources to Control Hyperalgesia: The Role of Endogenous Opioid Peptides

C. Queiroz-Junior, M. Caliari, D. Pacheco, 2012, Pharmacology.

Xylazine induced central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ-or κ-opioid receptors

I. Duarte, D. Pacheco, T. Romero, 2013, Brain Research.

δ-Opioid receptor agonist SNC80 elicits peripheral antinociception via δ1 and δ2 receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway

A. Perez, I. Duarte, D. Pacheco, 2005 .

The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/KATP pathway: Role of eNOS and nNOS.

V. Lemos, M. D. de Lima, M. E. Lima, 2017, Nitric oxide : biology and chemistry.

Involvement of GABA A receptor-associated chloride channels in the peripheral antinociceptive effect induced by GABA A receptor agonist muscimol.

A. Perez, I. Duarte, D. Pacheco, 2007, European journal of pharmacology.

Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.

A. Perez, I. Duarte, D. Pacheco, 2011, Life sciences.

Delta-opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels.

I. Duarte, D. Pacheco, 2005, European journal of pharmacology.

Participation of AT1 and Mas receptors in the modulation of inflammatory pain

A. Perez, I. Duarte, D. Pacheco, 2014, Peptides.

delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.

A. Perez, I. Duarte, D. Pacheco, 2005, Life sciences.

Inflammation Mobilizes Local Resources to Control Hyperalgesia: The Role of Endogenous Opioid Peptides

C. Queiroz-Junior, M. Caliari, D. Pacheco, 2012, Pharmacology.

PnPP‐19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase

A. K. Carmona, M. E. Lima, I. Duarte, 2016, British journal of pharmacology.